Usefulness of flow cytometric detection of cell surface interleukin-6 receptors in human myeloma cell lines

Clinical and Laboratory Haematology

Volumn 18, Issue 3, 1996, Pages 161-169

  Chen, Yi Hsiang ^a   Feng, Xin Xiang ^a   Hagen, K ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cytokine receptors; Flow cytometry; Glucocorticoid sensitivity; Interleukin 6 receptor; Myeloma cells

Indexed keywords

GLUCOCORTICOID; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MEMBRANE ANTIGEN; RECOMBINANT INTERLEUKIN 6;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL;

EID: 0029821723     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1996.00173.x     Document Type: Article

References (25)

1. Bataille R., Jourdan M., Zhang X-G. & Klein B. (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. Journal of Clinical Investigation 84, 2008-2011.
2. Bataille R., Barlogie B., Zhao Y-L. et al. (1995) Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood 86, 685-691.
3. Cerottini J-C. & Webb T. (1967) Preparation and use of specifically purified antibodies for immunofluorescent labelling. Acta Histochemica 27, 225-234.
4. Chen Y., Desai P., Shiao R-T., Lavelle D., Haleem A. & Chen J. (1996) Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites. Blood 87, 314-323.
5. Coulie P.G., Vanheckle A., Van Damme J. et al. (1987) High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-β2). different from those of type 1 interferon (α,β), on lymphoblastoid cells. European Journal of Immunology 17, 1435-1440.
6. Freeman G.J., Freeman A.S., Rabinowe S.N. et al (1989) Interleukin 6 gene expression in normal and neoplastic B cells. Journal of Clinical Investigation 83, 1512-1518.
7. Gonchoroff N.J., Greipp P.R., Kyle R.A. & Katzmann J.A. (1985) A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation. Cytometry 6, 506-512.
8. Hata H., Xiao H., Petrucci M.T., Woodliff J., Chang R. & Epstein J. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 81, 3357-3364.
9. Hitzler J.K., Martinez-Valdez H., Bergsagel D.B., Minden M.D. & Messner H.A. (1991) Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease. Blood 78, 1996-2004.
10. Ishikawa H., Tanaka H., Iwato K. et al. (1990) Effect of glucocorticoids on the biologic activities of myeloma cells: inhibition of interleukin-1β osteoclast activating factor-induced bone resorption. Blood 75, 715-720.
11. Kawano M., Hirano T., Matsuda T. et al. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332, 83-85.
12. Levy Y., Tsapis A. & Brouet J-C.L. (1991) Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. Journal of Clinical Investigation 88, 696-699.
13. Lindelov L.L., Christensen I.J. & Nissen N.I. (1983) A detergent method for the preparation of nuclei for flow-cytometric DNA analysis. Cytometry 3, 323-327.
14. Moali P.A., Pillay S., Weiner D., Leikin R. & Rosen S.T. (1992) A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood 79, 213-222.
15. Munck Peterson C., Davidsen O., Moestrup S.K., Sonne O., Nykjaer A., & Moller B.K. (1990) Cellular targets and receptors for interleukin-6. II. Characterization of IL-6 binding and receptors in peripheral blood cells and macrophages. European Journal of Clinical Investigation 20, 377-384.
16. Newman W., Dawson Beall L., Levine M.A., Cone J.L., Randhawa Z.I. & Bertolini D.R. (1989a) Biotinylated parathyroid hormone as a probe for the parathyroid hormone receptor. Structure-function analysis and detection of specific binding to cultured bone cells by flow cytometry. Journal of Biological Chemistry 264, 16359-16366.
17. Newman W., Dawson Beall L., Bertolini D.R. & Cone J.L. (1989b) Modulation of TGF-β type 1 receptor: Flow cytometric detection with biotinylated TGF-β. Journal of Cellular Physiology 141, 170-180.
18. Oonishi T., Sakashita K. & Uyesaka N. (1988) Flow cytometric studies of the binding of monoclonal antibodies OKT3, OKT4 and OKT8. Journal of Immunological Methods 115, 159-167.
19. Schwab G., Siegall C.B., Aarden L.A., Neckers L.M. & Nordan R.P. (1991) Characterization of an interleukin-6-mediated autocrine growth loop in the human myeloma cell line, U266. Blood 77, 587-593.
20. Taga T., Kawanishi Y., Hardy R.R., Hirano T. & Kishimoto T. (1987) Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. Journal of Experimental Medicine 166, 967-981.
21. Tobler A., Meier R., Seitz M., Dewald B., Baggiolini M. & Fay M.F. (1992) Glucocorticoids down regulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79, 45-51.
22. Wognum A.W., van Gils F.C.L.M. & Wagemaker G. (1993) Flow cytometric detection of receptors for interleukin-6 on bone marrow and peripheral blood cells in humans and rhesus monkeys. Blood 81, 2036-2043.
23. Wojchowski D.M. & Sytkowski A.J. (1986) Detection of low-density cell-surface molecules using biotinylated fluorescent microspheres. Biochimica et Biophysica Acta 857, 61-67.
24. Yamasaki K., Taga T., Hirata Y. et al. (1988) Cloning and expression of the human interleukin-6 (BSF-2/INF β2) receptor. Nature 241, 825-828.
25. Ziegler O., Cantin C., Germain L. et al. (1994) Insulin binding to human cultured lymphocytes measured by flow cytometry using three ligands. Cytometry 16, 339-345.